Article

Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer - one clinic experience.

2022-07-28

Abstract excerpt

<h4>Background: </h4> Triple negative breast cancer is heterogeneous BC molecular subtype. Pathological complete response (pCR) is important surrogate marker for progression free and overall survival. <h4>Aim: </h4> of study was to evaluate clinical and pathological factors that are associated with complete pathological response status in triple negative breast cancer receiving neoadjuvant chemotherapy. <h4>Materi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4070e2b3-255a-5182-b92d-2e8b37bca2df
DOI: 10.21203/rs.3.rs-1881015/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer - one clinic experience.DOI 10.21203/rs.3.rs-1881015/v1Read

Triple negative breast cancer: looking for the missing link between biology and treatments.Semantic proximity Read

How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategiesSemantic proximity Read

New Biomarkers and Treatment Advances in Triple-Negative Breast CancerSemantic proximity Read

BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients.Semantic proximity Read

Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC).Semantic proximity Read

Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancerSemantic proximity Read

Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of researchSemantic proximity Read

Molecular targets and therapies associated with poor prognosis of triple‑negative breast cancer (Review)Semantic proximity Read

Triple Negative Breast Cancer Subclassified by Immunohistochemistry: Correlation with Clinical and Pathological Outcomes in Patients Receiving Neoadjuvant ChemotherapySemantic proximity Read

Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.Semantic proximity Read

Triple-Negative Breast Cancer: Molecular Particularities Still a ChallengeSemantic proximity Read

Mutational Status is Associated with a Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer.Semantic proximity Read